MedPath

Monitored Effects of Physical Activity on Fetal Heart Rate by Using a Wireless Non-invasive Device

Not yet recruiting
Conditions
Fetal Distress
Registration Number
NCT06813859
Lead Sponsor
Balgrist University Hospital
Brief Summary

Effect of acute exercise testing in pregnant athletes on maternal and fetal heart rate, fetal/maternal bloodflow and cardiotocogramm assessment.

Detailed Description

The aim of the study is to evaluate in a preliminary step the validity of fetal heart rate measurement with the "Nemo Healthcare Monitoring System" - a wireless non-invasive CTG device. Furthermore, we will determine the reliability for CTG measurements (intraobserver and interobserver reliability) and for ultrasound (intraobserver reliability). The device is approved for use on pregnant women and is regularly used as a CTG device for monitoring fetal heart rate and contractions during childbirth. If in the preliminary step the heart rate measurements with the "Nemo Fetal Monitoring System" provide valid and fetal heart rate results compared to the standard Doppler ultrasound method and provide a reliable detection of fetal heart rate deceleration the effects of phys-ical activity on fetal heart rate pattern and changes in fetal blood flow, placento-fetal and materno-placental blood supply rate will be investigated in the main part of the study in a larger study population.

It is hypothesized that CTG provides technically a valid and reliable continuous re-cording of fetal heart rate values, since fetal heart rate measurement under physical exertion has previously only been possible by intermittent but not continuous Dop-pler ultrasound. Furthermore, we will evaluate alterations in fetal heart rate pattern and changes in fetal blood flow, placento-fetal and materno-placental blood supply according to the level of exertion.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
20
Inclusion Criteria
  • Presence of signed informed consent form
  • healthy pregnant active female over the age of 18 years and below 45 years
  • sporting activity >4h/week on 2 or more weekdays
  • single pregnancy, between 28+0 and 34+0 weeks of pregnancy
Exclusion Criteria
  • No signed informed consent form or revocation of consent
  • pre-existing pregnancy complications

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
fetal heart ratethrough exercise testing, an average of 90 minutes

The fetal heart rate is continuously monitored via the CTG device during the entire performance test.

Secondary Outcome Measures
NameTimeMethod
Umbilical cord artery pulsatility indexthrough exercise testing, an average of 90 minutes

(systolic velocity - diastolic velocity) / mean velocity

Umbilical cord artery resistance indexthrough exercise testing, an average of 90 minutes

(systolic velocity - diastolic velocity) / systolic velocity

umbilical cord artery S/D ratiothrough exercise testing, an average of 90 minutes

(S = maximum systolic flow velocity; D = maximum diastolic flow velocity)

Medial cerebral artery pulsatility indexthrough exercise testing, an average of 90 minutes

(systolic velocity - diastolic velocity) / mean velocity

Medial cerebral artery resistance indexthrough exercise testing, an average of 90 minutes

(systolic velocity - diastolic velocity) / systolic velocity

medial cerebral artery peak systolic velocitythrough exercise testing, an average of 90 minutes

in cm/s

right and left uterine artery pulsatility indexthrough exercise testing, an average of 90 minutes

(systolic velocity - diastolic velocity) / mean velocity

right and left uterine artery resistance indexthrough exercise testing, an average of 90 minutes

(systolic velocity - diastolic velocity) / systolic velocity

cerebro-placental ratiothrough exercise testing, an average of 90 minutes

pulsatility index of the middle cerebral artery / pulsatility index of the umbilical artery

pregnancy complicationsduring pregnancy and up to12 weeks after birth

incidence of pregnancy complications (yes/no);

birth complicationsOn the day the child is born

incidence of birth complications (yes/no);

mode of deliveryOn the day the child is born

spontaneous birth vs. vacuum-assisted birth vs. forceps-assisted birth vs planned cesarean section vs. unplanned cesarean section

APGAR scoreOn the day the child is born

APGAR score (1-10)

gestational age at birthOn the day the child is born

gestational age at birth (in weeks and days);

pH value of the umbilical cord arteryOn the day the child is born

pH value of the umbilical cord artery mesured directly after birth

fetal admission to Neonatal Intensive Care Unitup to 12 weeks

admission (yes/no)

© Copyright 2025. All Rights Reserved by MedPath